Liver tumor detection AI study for cirrhosis patients
Part of Cancer, Digestive system clinical trials.
This trial tests an AI tool to find and classify liver tumors in people with cirrhosis or extrahepatic cancer who've had a non-contrast CT scan. You may join if you have cirrhosis or a cancer outside the liver, but not if you already have a malignant liver tumor or have had a liver transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have had a CT scan of your chest or belly that didn't use a contrast dye (non-contrast), and it covered your liver
- You have been diagnosed with cirrhosis (scarring of the liver)
- Or you have been diagnosed with a cancer that started outside your liver
- You do not have a malignant (cancerous) liver tumor already diagnosed
- You have not had a liver transplant, and your CT scan is of good quality without major artifacts or noise
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses digital scans of your tumor tissue and CT/MRI images to build a computer model that helps predict whether you might need extra treatment (adjuvant therapy) after liver cancer surgery. The goal is to use your own tissue and scan data to personalize follow-up care.
This study uses artificial intelligence to analyze CT scans before and during liver surgery. It aims to build a decision-making system to help doctors better plan and perform surgery for liver cancer or other growths.
This trial uses an AI system to help doctors plan surgery for liver cancer. It is for people who have had a CT scan of their liver and may or may not have a liver tumor.
This study compares an artificial intelligence tool against a standard liver scan scoring system (LI-RADS) to diagnose liver cancer (HCC) on CT scans. It may help make liver cancer detection more accurate for people at higher risk.
This study tests whether an AI tool can help doctors read CT scans of the liver to find cancerous spots. If you have had a CT scan of your abdomen with specific timing, you might be able to join.
This trial uses artificial intelligence to help doctors better stage (classify the severity of) and plan treatment for hepatocellular carcinoma, a type of primary liver cancer. Researchers will collect your clinical information and imaging to see if AI can improve decision-making about your care.
Hear when a new Liver Malignancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.